AMWL AMERICAN WELL CORP

Amwell® to report first quarter 2025 operating results

Amwell® to report first quarter 2025 operating results

BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025.

Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.

The full earnings report and the live audio webcast can be accessed by visiting the of the company's website. A webcast replay of the call will be available at for approximately 90 days.

About Amwell  

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or .

©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell Converge™, Carepoint™ and the Amwell Logo are registered trademarks of American Well Corporation.



Investors:

Sue Dooley

415.602.9167

 

Media:

Angela Vogen

 
EN
17/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AMERICAN WELL CORP

 PRESS RELEASE

Amwell® to participate in upcoming investor conferences

Amwell® to participate in upcoming investor conferences BOSTON, April 24, 2025 (GLOBE NEWSWIRE) --  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences:   On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually. On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Confere...

 PRESS RELEASE

Amwell® to report first quarter 2025 operating results

Amwell® to report first quarter 2025 operating results BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the of the company's website. A...

 PRESS RELEASE

Amwell makes inducement grant

Amwell makes inducement grant BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky’s employment as Amwell’s chief product and technology officer. The RSUs become vested as follows, subject to Zamansky’s continued employment through each vesting date, except as noted below: 25% of the RSUs will vest on the six-month anniversary of the...

 PRESS RELEASE

Amwell announces innovation leader as chief product and technology off...

Amwell announces innovation leader as chief product and technology officer Amazon veteran Dan Zamansky joins company’s executive team BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company’s new chief product and technology officer, effective today. Zamansky will lead the company's product and R&D organizations. He will focus on the comprehensive technology-enabled care platform Amwell offers payers and health systems to provide individuals with better access...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch